Finance

Beta
Lists
FATE:NASDAQ
Fate Therapeutics Inc
$2.84
+7.98%
(+0.21) 1D
$2.81
-1.02% (-0.029)
After hours
Closed: May 29, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for FATE...
Open
$2.68
High
$2.88
Low
$2.64
Mkt. cap
331.03M
Avg. vol.
3.61M
Volume
5.19M
52-wk high
$2.88
52-wk low
$0.91
EPS
-$1.09
Beta
2.13
Shares outstanding
116.56M
No. of employees
161
Open
$2.68
High
$2.88
Low
$2.64
Mkt. cap
331.03M
Avg. vol.
3.61M
Volume
5.19M
52-wk high
$2.88
52-wk low
$0.91
EPS
-$1.09
Beta
2.13
Shares outstanding
116.56M
No. of employees
161
News stories
From sources across the web
About Fate Therapeutics Inc
CEOScott Wolchko
Employees161
Founded2007
Headquarters-
SectorBiotechnology
Websitefatetherapeutics.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
1.91M
1.74M
1.37M
1.30M
Cost of goods sold
3.82M
25.84M
9.50M
24.70M
Cost of revenue
3.82M
25.84M
9.50M
24.70M
Research and development expenses
23.61M
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
11.44M
10.64M
25.50M
9.60M
Operating expense
35.05M
10.64M
25.50M
9.60M
Total operating expenses
38.88M
36.48M
34.99M
34.30M
Operating income
-36.97M
-34.74M
-33.62M
-33.00M
Other non operating income
-23.00K
-90.00K
127.00K
-80.00K
EBT including unusual items
-34.07M
-32.25M
-32.37M
-31.21M
EBT excluding unusual items
-34.07M
-32.25M
-31.27M
-31.21M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-34.07M
-32.25M
-32.37M
-31.21M
Net profit margin
-1,786.58%
-1,852.38%
-2,364.79%
-2,402.85%
Earnings per share
-0.29
-0.27
-0.27
-0.26
Interest and investment income
2.92M
2.58M
2.22M
1.87M
Interest expense
-
-
-
-
Net interest expenses
2.92M
2.58M
2.22M
1.87M
Depreciation and amortization charges
-
-
-
-
EBITDA
-33.69M
-31.51M
-30.56M
-30.08M
Gain or loss from assets sale
-36.00K
-
45.00K
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer